View in EDS

Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.

Saved in:
Bibliographic Details
Title: Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
Authors: Hyams C; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.; Academic Respiratory Unit, University of Bristol, UK., Challen R; Engineering Mathematics, University of Bristol, UK., Begier E; Global Medical Development Scientific and Clinical Affairs, Pfizer Vaccines, Ireland., Southern J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., King J; Clinical Research and Imaging Centre, UHBW NHS Trust, Bristol, UK., Morley A; Academic Respiratory Unit, University of Bristol, UK., Szasz-Benczur Z; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK., Gonzalez MG; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK., Kinney J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., Gray S; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Oliver J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., Hubler R; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Valluri S; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Vyse A; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., McLaughlin JM; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Ellsbury G; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., Maskell NA; Academic Respiratory Unit, University of Bristol, UK., Gessner BD; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Danon L; Engineering Mathematics, University of Bristol, UK., Finn A; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
Corporate Authors: Avon CAP Research Group
Source: The Lancet regional health. Europe [Lancet Reg Health Eur] 2022 Oct; Vol. 21, pp. 100473. Date of Electronic Publication: 2022 Aug 08.
Publication Type: Journal Article
Journal Info: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35965672
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hyams+C%22">Hyams C</searchLink>; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.; Academic Respiratory Unit, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Challen+R%22">Challen R</searchLink>; Engineering Mathematics, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Begier+E%22">Begier E</searchLink>; Global Medical Development Scientific and Clinical Affairs, Pfizer Vaccines, Ireland.<br /><searchLink fieldCode="AU" term="%22Southern+J%22">Southern J</searchLink>; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22King+J%22">King J</searchLink>; Clinical Research and Imaging Centre, UHBW NHS Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Morley+A%22">Morley A</searchLink>; Academic Respiratory Unit, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Szasz-Benczur+Z%22">Szasz-Benczur Z</searchLink>; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Gonzalez+MG%22">Gonzalez MG</searchLink>; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Kinney+J%22">Kinney J</searchLink>; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Campling+J%22">Campling J</searchLink>; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Gray+S%22">Gray S</searchLink>; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Oliver+J%22">Oliver J</searchLink>; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Hubler+R%22">Hubler R</searchLink>; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Valluri+S%22">Valluri S</searchLink>; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vyse+A%22">Vyse A</searchLink>; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22McLaughlin+JM%22">McLaughlin JM</searchLink>; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ellsbury+G%22">Ellsbury G</searchLink>; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Maskell+NA%22">Maskell NA</searchLink>; Academic Respiratory Unit, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Gessner+BD%22">Gessner BD</searchLink>; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Danon+L%22">Danon L</searchLink>; Engineering Mathematics, University of Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Finn+A%22">Finn A</searchLink>; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Avon+CAP+Research+Group%22">Avon CAP Research Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101777707%22">The Lancet regional health. Europe</searchLink> [Lancet Reg Health Eur] 2022 Oct; Vol. 21, pp. 100473. <i>Date of Electronic Publication: </i>2022 Aug 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22[Oxford]%22">[Oxford] </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101777707 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-7762 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226667762%22">26667762 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Reg Health Eur <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35965672
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lanepe.2022.100473
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100473
    Titles:
      – TitleFull: Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hyams C
      – PersonEntity:
          Name:
            NameFull: Challen R
      – PersonEntity:
          Name:
            NameFull: Begier E
      – PersonEntity:
          Name:
            NameFull: Southern J
      – PersonEntity:
          Name:
            NameFull: King J
      – PersonEntity:
          Name:
            NameFull: Morley A
      – PersonEntity:
          Name:
            NameFull: Szasz-Benczur Z
      – PersonEntity:
          Name:
            NameFull: Gonzalez MG
      – PersonEntity:
          Name:
            NameFull: Kinney J
      – PersonEntity:
          Name:
            NameFull: Campling J
      – PersonEntity:
          Name:
            NameFull: Gray S
      – PersonEntity:
          Name:
            NameFull: Oliver J
      – PersonEntity:
          Name:
            NameFull: Hubler R
      – PersonEntity:
          Name:
            NameFull: Valluri S
      – PersonEntity:
          Name:
            NameFull: Vyse A
      – PersonEntity:
          Name:
            NameFull: McLaughlin JM
      – PersonEntity:
          Name:
            NameFull: Ellsbury G
      – PersonEntity:
          Name:
            NameFull: Maskell NA
      – PersonEntity:
          Name:
            NameFull: Gessner BD
      – PersonEntity:
          Name:
            NameFull: Danon L
      – PersonEntity:
          Name:
            NameFull: Finn A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2666-7762
          Numbering:
            – Type: volume
              Value: 21
          Titles:
            – TitleFull: The Lancet regional health. Europe
              Type: main
ResultId 1